Cardiovascular risk and Obesity in sleep apnea syndrome assessed with the Stop-Bang questionnaire

Show simple item record

dc.contributor.author Vicente-Herrero, M.T.
dc.contributor.author Capdevila Garcia, L.
dc.contributor.author Bellido Cambrón, M.C.
dc.contributor.author Ramirez Iñiguez de la Torre, M.V.
dc.contributor.author Lladosa Marco, S.
dc.date.accessioned 2019-12-13T07:44:45Z
dc.identifier.uri http://hdl.handle.net/11201/150455
dc.description.abstract [eng] INTRODUCTION: Sleep disorders include a number of different processes, of which the most prevalent is the sleep apnea-hypopnea syndrome (SAHS). Prevalence of SAHS has increased worldwide, and has a significant social and health impact because of the increased cardiometabolic risk attributed to obesity and the associated metabolic syndrome. MATERIAL AND METHODS: A cross-sectional epidemiological study of 1110 workers from public service companies in the Spanish Mediterranean area (Balearic Islands and Valencian Community) was conducted between January and December 2015. Cardiovascular risk was calculated using the Castelli, Kannel and TG/HDL indices, and prevalence of obesity using body mass index, waist circumference, waist-height ratio, and visceral fat. SAHS risk was assessed using the Stop-Bang questionnaire. RESULTS: Risk of SAHS was low in 77% of patients and intermediate-high in 23% of patients. All obesity parameters showed a statistically significant association (p value <.001) with intermediate/high risk of SAHS. Obesity prevalence is higher the worse the quality of sleep. There was a statistically significant relationship between risk of SAHS and cardiovascular risk with the atherogenic indexes found. CONCLUSIONS: Twenty-three percent of workers had intermediate/high SAHS risk. The results of this study support the relationship of SAHS with an increased CVR and with obesity parameters. Further prospective studies in different productive sectors may be useful to confirm the results of this research
dc.format application/pdf
dc.relation.isformatof https://doi.org/10.1016/j.endien.2017.09.002
dc.relation.ispartof Endocrinología, Diabetes y Nitrición, 2017, vol. 64, num. 10, p. 544-551
dc.rights , 2017
dc.subject.classification 616 - Patologia. Medicina clínica. Oncologia
dc.subject.other 616 - Pathology. Clinical medicine
dc.title Cardiovascular risk and Obesity in sleep apnea syndrome assessed with the Stop-Bang questionnaire
dc.type info:eu-repo/semantics/article
dc.date.updated 2019-12-13T07:44:45Z
dc.date.embargoEndDate info:eu-repo/date/embargoEnd/2026-12-31
dc.embargo 2026-12-31
dc.rights.accessRights info:eu-repo/semantics/embargoedAccess
dc.identifier.doi https://doi.org/10.1016/j.endien.2017.09.002


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Repository


Advanced Search

Browse

My Account

Statistics